• Health Department Launches Monkeypox Vaccine Clinic for People Who May Have Been Exposed to Monkeypox - (06/25/22)
   
  
• Lenacapavir for HIV-1 - Potential Promise of a Long-Acting Antiretroviral Drug - EDITORIAL - (06/25/22)
   
  
• Investigational Lenacapavir Receives Positive CHMP Opinion for People With Multi-Drug Resistant HIV - (06/25/22)
   
  
• A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001) - (06/21/22)
   
  
• THE EFFECT OF MENOPAUSAL STATUS, AGE, AND HIV ON NON-AIDS COMORBIDITY BURDEN AMONG U.S. WOMEN - (06/20/22)
   
  
• Disability Measured in PLWH in London: 39.5% Severe Disability; 70.5% Moderate Disability - (06/03/22)
   
  
• bNabs Combination Study new reports & antibody-resistance - (06/02/22)
   
  
• PLWH Had 3 X Worse Fatigue. Fatigue associated with Worse Cognition, Daily Functioning - (06/02/22)
   
  
• Medicines Patent Pool, ViiV Healthcare enter negotiations over voluntary licensing of cabotegravir Long-Acting for HIV pre-exposure prophylaxis - (06/01/22)
   
  
• PLWH Had 3x Worse Fatigue. Fatigue Associated with Worse Cognition (but not in HIV-neg.) & Worse Daily Function in PLWH - (06/01/22)
   
  
• COVID 5th Wave So Africa - Boosters "Stay Up-To-date" White House Briefing - (06/01/22)
   
  
• Cocrystal Pharma Expands Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate COVID-19 Protease Inhibitors - (06/01/22)
   
  
• Brain Affects by Integrase Inhibitors & ARTs - Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors - (05/31/22)
   
  
• Maraviroc-Does it Improve Cognitive Function? New Research This Week in Mice - (05/31/22)
   
  
• Interferon therapy shows striking results against COVID-19 - (05/31/22)
   
  
• Peginterferon Lambda Single Injection for Newly Diagnosed COVID - TOGETHER Phase 3 Study - (05/31/22)
   
  
• Interferon [lambda] therapy shows striking results against COVID-19 - (05/31/22)
   
  
More HIV Articles...
 

More News Updates Articles...
 

• EASL: Voxilaprevir/Velpatasvir/Sofosbuvir Efficacy in hepatitis C patients previously treated with direct-acting antiviral agents (DAA) VOX/VEL/SOF Effective Rescue After DAA Failure-With Limits - Mark Mascolini (06/25/22)
   
  
• EASL: Effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients previously treated with direct-acting antiviral agents (DAA) - (06/25/22)
   
  
More Hep C Articles...
 

• EASL: Real life study of bulevirtide in chronic hepatitis Delta: preliminary results of the ANRS I MIE HD EP01 HDV prospective cohort - (06/26/22)
   
  
• EASL: Antios Therapeutics' ATI-2173 Demonstrates Suppression of Hepatitis B Virus in Phase 2a Study; ATI-1428 and ATI-1645 Exhibit Potent Antiviral Activity in a Nonclinical Study - (06/26/22)
   
  
• EASL: Improving the pharmacokinetic profile of the hepatitis B virus core inhibitor ABI-H3733 following oral administration: results from new formulation activities - (06/26/22)
   
  
• EASL: Deeper virologic suppression with the addition of vebicorvir, a first-generation hepatitis B core inhibitor, to entecavir correlates with reduced inflammation and fibrosis-4 index in treatment-naïve patients with HBeAg positive chronic hepatitis B - (06/26/22)
   
  
• EASL: Sustained 12 Week Off Treatment Antiviral Efficacy of ATI-2173, a Novel Active Site Polymerase Inhibitor Nucleotide (ASPIN), Combined With Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients, a Phase 2a Clinical Trial - (06/26/22)
   
  
• EASL: Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection: interim results from the randomised Phase 2b B-Clear study - (06/26/22)
   
  
• EASL: Therapeutic Vaccine JNJ-0535 Induces a Strong HBV-specific T-cell Response in Healthy Adults and a Modest Response in Chronic HBV-infected Patients VOX/VEL/SOF Effective Rescue After DAA Failure-With Limits - (06/26/22)
   
  
More Hep B Articles...
 

List not necessarily listed here in order of date being held.